[Antiviral therapy today].
Many drugs are know to be capable to interfering with viral multiplication. Upon clinical testing, however, only some of these appear to possess sufficient therapeutic effectiveness to recommend their use. The action mechanism of these, their possible side effects, the data proving their effectiveness and the main unsolved problems for their use are analysed.
D000547:Amantadine / Q000627:therapeutic use; D000998:Antiviral Agents / Q000627:therapeutic use*; D003561:Cytarabine / Q000627:therapeutic use; D006801:Humans; D007070:Immunoglobulin A / Q000627:therapeutic use; D007542:Inosine Pranobex / Q000627:therapeutic use; D007372:Interferons / Q000627:therapeutic use; D007978:Levamisole / Q000627:therapeutic use; D012141:Respiratory Tract Infections / Q000188:drug therapy*; D013951:Thymus Hormones / Q000627:therapeutic use; D014740:Vidarabine / Q000627:therapeutic use; D014777:Virus Diseases / Q000188:drug therapy*
D000998:Antiviral Agents; D007070:Immunoglobulin A; D013951:Thymus Hormones; D003561:Cytarabine; D007978:Levamisole; D007372:Interferons; D000547:Amantadine; D014740:Vidarabine; D007542:Inosine Pranobex
Terapia antivirale oggi.